Literature DB >> 9302276

Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.

G A Carlson1, D R Borchelt, A Dake, S Turner, V Danielson, J D Coffin, C Eckman, J Meiners, S P Nilsen, S G Younkin, K K Hsiao.   

Abstract

Overexpression of Alzheimer amyloid precursor protein (APP) produces dramatically different phenotypes in transgenic mice depending on the genetic background. For example, concentrations of APP that produce amyloid plaques in outbred transgenic lines are lethal for inbred FVB/N or C57BL/6J mice. Expression of SOD1 transgenes is protective, suggesting involvement of oxidative damage in premature death, but ablation of Apoe had no significant effect. In contrast, FGF2 transgene overexpression enhances the lethal effects of APP. Differential survival does not appear to reflect genetic differences in APP processing, but rather host responses to APP or its derivatives.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302276     DOI: 10.1093/hmg/6.11.1951

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  55 in total

Review 1.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Telomerase immortalization of principal cells from mouse collecting duct.

Authors:  Stacy L Steele; Yongren Wu; Robert J Kolb; Monika Gooz; Courtney J Haycraft; Kent T Keyser; Lisa Guay-Woodford; Hai Yao; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

Review 3.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

4.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease.

Authors:  Ling Li; Dongfeng Cao; David W Garber; Helen Kim; Ken-ichiro Fukuchi
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  In vivo reduction of amyloid-beta by a mutant copper transporter.

Authors:  Amie L Phinney; Bettina Drisaldi; Stephen D Schmidt; Stan Lugowski; Veronica Coronado; Yan Liang; Patrick Horne; Jing Yang; Joannis Sekoulidis; Janaky Coomaraswamy; M Azhar Chishti; Diane W Cox; Paul M Mathews; Ralph A Nixon; George A Carlson; Peter St George-Hyslop; David Westaway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

6.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

Review 7.  Neurodegenerative Disease Transmission and Transgenesis in Mice.

Authors:  Brittany N Dugger; Daniel P Perl; George A Carlson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

8.  Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions.

Authors:  Kristin Derlig; Andreas Gießl; Johann Helmut Brandstätter; Ralf Enz; Regina Dahlhaus
Journal:  J Vis Exp       Date:  2016-04-21       Impact factor: 1.355

9.  Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.

Authors:  V Askanas; W K Engel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 10.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.